Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709)

PHASE3CompletedINTERVENTIONAL

Enrollment

538

Participants

Timeline

Start Date

November 20, 2007

Primary Completion Date

December 21, 2009

Study Completion Date

December 21, 2009

Conditions

InsomniaSleep Initiation and Maintenance DisordersMental DisordersDyssomniasSleep Disorders

Interventions

DRUG

Esmirtazapine

one tablet daily

DRUG

Placebo

one tablet daily

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00561821 - Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709) | Biotech Hunter | Biotech Hunter